Enhanced Care for Patients With Complex Multimorbidity in Primary Care (MM600-DK)

February 18, 2026 updated by: University of Copenhagen

Effectiveness of an Adaptive, Complex Intervention to Enhance Care for Patients With Complex Multimorbidity in General Practice - a Pragmatic Cluster Randomized Controlled Trial

Introduction Patients living with a chronic disease often have more than one chronic condition, which is referred to as multimorbidity. Multimorbidity is associated with decreased quality of life, functional decline, polypharmacy, and increased healthcare utilization. Patients with multimorbidity often have a high symptom- and treatment burden, and have to attend multiple appointments, often at numerous locations, and comply with complex or even conflicting advice and drug regimens, resulting in an increased risk of depression and low quality of life. In Denmark, general practice is the key organizational setting in terms of offering people with complex multimorbidity integrated, longitudinal, patient-centered care. However, caring for patients with multimorbidity is a complex and time-consuming task and the organization of chronic care in general practice is organized around individual conditions.

Research question The objective of the study is to evaluate the effectiveness of a complex intervention consisting of a prolonged consultation and a strengthened cross-sectoral collaboration for patients with complex multimorbidity listed in participating practices on the patients' health-related quality of life, health and use of health-services.

Methods

Design:

A pragmatic, adaptive, cluster-randomized, non-blinded, parallel-group trial conducted in general practice in all regions in Denmark evaluating a complex intervention.

Study Overview

Study Type

Interventional

Enrollment (Actual)

117000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2700
        • General practices in all of Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Adult (18 years or older) patients listed at participating GPs living in their own home with

  • Two or more chronic conditions from two of ten diagnosis groups OR who were identified by the GP with complex multimorbidity (see box 1)
  • At least one contact with secondary care in 2022 or 2023.
  • Prescribed at least five prescription drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The intervention consists of 1) an extended overview consultation lasting 30-45 minutes in general practice, 2) access to cross-sectoral video conferences with secondary care specialists and 3) an instruction material for GPs on how to organize the intervention and 4) an adaptive toolbox to support elements in the intervention (not yet developed)
No Intervention: Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Needs-based quality of life measured with MMQ1 - PROM
Time Frame: 2 years

The primary outcome is needs-based quality of life measured with MMQ1 (unpublished at present). The outcome consist of six unidimensional domains; physical capacity, worries, limitations in daily activities, social life, self-image and economy with a scale from 0-3 per item (sum scores differ due to differences in the number f items) We expect our intervention to be able to affect the three domains; worries, limitations in daily life and social life.

We will consider a clinically significant improvement in at least one domain as a success.

2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment burden (MMQ1-TB) - PROM
Time Frame: 2 years

Under validation. The PROM consists of six domains with response categories from 0-3.

a high score means high burden (negative)

2 years
Patient-perceived patient-centeredness of consultations (PCC-GP) -PROM
Time Frame: 2 years
Under validation, The PROM consists of eight domains with response categories from 0-3. a high score means high patient-centeredness (positive)
2 years
Mortality - registry-based
Time Frame: 2 years
Number of deaths in each group per patient-years at risk
2 years
Hospitalizations - registry-based
Time Frame: 2 years
Number of hospitalizations in each group in total and per patient-years at risk. Any admittance to the hospital counts regardless if it is planned or unplanned and regardless the duration.
2 years
Nursing home placement registry-based
Time Frame: 2 years
Number of nursing home placements in each group in total and per patient year at risk
2 years
number of prescription medicines - registry-based
Time Frame: 2 years
Number of prescription medicines per patient in each group (as a count regardless indication)
2 years
Polypharmacy - registry-based
Time Frame: 2 years
Number of patients with polypharmacy (more than 5 prescription drugs) in each group
2 years
GP work satisfaction related to care for patients with multimorbidity - questionnaire
Time Frame: 2 years
We have developed six items regarding work satisfaction/burden in relation to working with patients with MM in general practice. A clinically significant difference between the groups in at least one of the items will be considered a success.
2 years
GP burn-out - questionnaire
Time Frame: 2 years
If we get access to the national GP burnout questionnaire data, we will use the data to report this outcome. But the outcome depends on the questionnaire being distributed at an appropriate time which is not currently yet planned.
2 years
Use of health services in general practice registry-based
Time Frame: 2 years
This outcome combines all use of health services in general practice regardless contact form. It will be measured as number of contacts
2 years
Use of other primary care health services (such as private specialists and out-of-hours care) registry-based.
Time Frame: 2 years
All contacts in primary care will be combined and the number of contacts compared between groups
2 years
Use of outpatient and other planned health services in secondary care (including new referrals), registry-based
Time Frame: 2 years
All contacts in secondary care will be combined and the number of contacts compared between groups
2 years
Health service use in the municipalities - registry-based
Time Frame: 2 years
All contacts in the municipalities regarding health and rehabilitation will be combined and the number of contacts compared between groups
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Actual)

October 29, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

December 16, 2022

First Submitted That Met QC Criteria

January 4, 2023

First Posted (Actual)

January 9, 2023

Study Record Updates

Last Update Posted (Actual)

February 20, 2026

Last Update Submitted That Met QC Criteria

February 18, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multimorbidity

Subscribe